Genetic Testing: Market Research Report

Date: January 5, 2015
Pages: 343
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G6B8B51407CEN
Leaflet:

Download PDF Leaflet

Genetic Testing: Market Research Report
This report analyzes the worldwide markets for Genetic Testing in US$ Million by the following Product Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 86 companies including many key and niche players such as -
  • Abbott Laboratories
  • AutoGenomics, Inc.
  • BioRad Laboratories
  • ELITech Group S.P.A
  • PerkinElmer, Inc.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Prenatal Diagnosis and Newborn Genetic Testing
Pharmacogenetics/Pharmacogenomics
Predictive Diagnostics

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

A Curtain Raiser
Top Ten Genetic Disorders Worldwide
Genetic Testing: Heralding a New Era
Genetic Testing Paves the Way for Personalized Medicine

Table 1. Drug Ineffectiveness for Select Therapeutic Categories - Necessitating Personalized Medicine (includes corresponding Graph/Chart)

Ballooning Global Population Offers Increased Growth Opportunities

Table 2. Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2015 (As of May’15)

Aging Population Drives the Genetic Testing Market

Table 3. Global Population Statistics for the 65+ Age Group (2014) (includes corresponding Graph/Chart)
Table 4. Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 5. Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Table 6. Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Improving Healthcare Expenditure to Drive Demand

Table 7. Per-Capita Healthcare Expenditure in Select Regions: 2014 (includes corresponding Graph/Chart)
Table 8. Healthcare Spending as a Percentage of GDP by Region: 2014 (includes corresponding Graph/Chart)

Genetic Testing – A Critical Part of the Rapidly Developing In-Vitro Diagnostics (IVD) Market

Table 9. Global In Vitro Diagnostics (IVD) Market by Geographic Region (2014): Percentage Share Breakdown of Revenues for the United States, Europe, and Rest of World (includes corresponding Graph/Chart)
Table 10. Global In-Vitro Diagnostics Market by Sector (2014): Percentage Breakdown of Revenues for Hospital & Commercial Laboratories, and Decentralized & Patient Self-Testing (includes corresponding Graph/Chart)
Table 11. Global In-Vitro Diagnostics Market by Segment (2014): Percentage Breakdown of Value Sales for Hematology, Hemostasis, Immunochemistry, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, Self-Monitoring Blood Glucose, and Tissue Diagnostics (includes corresponding Graph/Chart)
Table 12. Global In Vitro Diagnostics Market by Leading Player (2014): Percentage Share Breakdown of Revenues for Abbott, Biomerieux, Danaher, J&J, Roche, Siemens and Others (includes corresponding Graph/Chart)

Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market

Table 13. Global Molecular Diagnostics Market (2014): Percentage Breakdown of Market Revenues of Infectious Disease Testing, Genomics, and Blood Donor Screening (includes corresponding Graph/Chart)

Biomarker Discovery Leads to Advanced Genetic Testing
List of US-FDA Approved Biomarkers for Cancer

2. SEGMENTAL REVIEW

Prenatal Testing Market to Rise
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Prenatal Testing – Changing the World of Pregnancy Care
Prenatal Testing – A Rudimentary Overview
List of Available Prenatal Screening and Diagnostic Tests by Indication
Conventional Pre-Natal Diagnostic Techniques – A Risky Affair
Other Negativities of Existing Invasive Techniques
Emergence of Non-Invasive Prenatal Diagnosis (NIPD)
Competition Intensifies in the NIPD Market
Commercially Available NIPD (Genetic) Tests for Aneuploidy in the US
NIPD Eliminates Risks and Uncertainty of Conventional Diagnostic Procedures
Opposition to NIPD Technique – A Significant Hurdle to Adoption
Ethical Issues Bog Down Benefits and Proliferation of Prenatal Testing
Benefits Outweigh Snags in NIPD Tests
Major Factors Influencing Penetration of NIPD Tests

Table 14. Price Comparison of Existing Tests and Screening Procedures for Down’s Syndrome

Diversity in NIPD Usage on the Cards
Expanded Newborn Screening
Predictive Diagnostics
Breast Cancer Gene Testing Market to Expand Strongly
Myriad Genetics – The Unquestioned Leader in Breast Cancer Testing
Routine Clinical Testing Vs. Predictive Genetic Testing
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
Discovery of Novel Biomarkers Crucial to Predictive Diagnostics
Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
Dearth of Genetic Counselors – A Major Hurdle for the Predictive Genetic Testing
Pharmacogenomics Development Augurs Growth of Genetic Testing Market

3. MARKET TRENDS

Direct-to-Consumer Genetic Testing – A Key Trend in the Genetic Testing Market
Creating a Platform for New Companies
Business Models for DTC Genetic Testing Firms
Growing Prominence of DTC Genetic Testing: A Boon or a Curse?
Pre-implantation Genetic Diagnosis (PGD) - A Major Driver for the Genetic Testing Market
Whole Genome Sequencing – Boon or Bane to Genetic Testing?
Validity of Emerging Genetic Tests for Alzheimer’s
Utility of Genetic Testing for Warfarin Study
Oncology – A Key Focus Area for Genetic Testing

Table 15. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
Table 16. New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
Table 17. Cancer Incidence in Developed Nations By Site: 2012 (includes corresponding Graph/Chart)
Table 18. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
Table 19. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
Table 20. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)

Genetic Testing May Aid CNS Disease Therapeutics
Neurodegenerative Diseases - Major Focus Area for Genetic Testing
Alzheimer’s Disease
Huntington’s Disease
Genetic Testing – An Indispensible Tool for Cystic Fibrosis

Table 21. Most Common Mutations and Worldwide Frequency (includes corresponding Graph/Chart)

Histocompatibility Testing

Table 22. Global HLA Testing Market (2012-2016E): Revenue Estimates for 2012, 2013, 2014, 2015, and 2016 (includes corresponding Graph/Chart)

Next-Generation Sequencing – A Giant Leap in Genome Sequencing
Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance
Better Regulatory Safeguards Required for Global Genetic Testing Industry
Challenges Faced
Genetic Counseling: Gaining Momentum
Online Approach Gains Momentum
Recommendations of ACOG and ACGM Augments Demand for Cystic Fibrosis Testing
Ethical Issues & Need for Appropriate Regulating Policies
Issues Related to Genetic Tests for Obesity
Diagnosis and Treatment during Pregnancy - An Effective Way of Alleviating Syphilis Related Deaths and Stillbirths

4. MOLECULAR DIAGNOSTICS MARKET – AN INSIGHT

Global Molecular Diagnostics on a High Growth Curve
Automation Driving Global Market
Molecular Diagnostics: Marking the Convergence of Numerous Technologies
MDx Market for Infectious Diseases Zooming Ahead
Aging Population, Disease Incidence – Fundamental Drivers of Growth
Pharmaceutical Firms Carving Their Niche in Molecular Diagnostics Market
Towards Tailoring the Right Treatment for the Right Disease
Limited Reimbursements by Third Party Payers – A Stumbling Block
Disease-Specific Molecular Diagnostics to Deliver Improved Clinical Outcomes
Molecular Diagnostics and Intellectual Property
Business Opportunities in the Offing
Medical Training and Practice Challenges
Hurdles All the Way for Companies Eyeing Molecular Diagnostics
Product Marketing – Key to Commercial Success
Integration of Molecular Diagnostics into Therapeutics
Molecular Diagnostics – Moving from Centralization to Decentralization
Competitive Landscape of the Molecular Diagnostics Market

Table 23. Leading Players in the Global Molecular Diagnostics Market (2014): Percentage Share Breakdown by Value Sales for Abbott, Becton, Dickinson & Company, bioM?rieux, Cepheid, Hologic/Gen-Probe, Novartis, Qiagen, Roche Diagnostics, Siemens and Others (includes corresponding Graph/Chart)

Other Noteworthy Companies and their Competitive Position by Segment
New Entrants Eye Unmet Needs

5. PRODUCT OVERVIEW

Preface to Genetic Testing
Genetic Testing and its Applications
Gene Candidate and Genome Screen
‘DNA Chip’ to Chip into Genetic Field
Techniques Used to Identify Changes in Genes
Types of Genetic Testing
Prenatal Diagnosis
Cancer Testing
Carrier Identification
Newborn Screening
Predictive Testing
Pre-Symptomatic Testing
Cytogenetic Tests
Steps in Genetic Testing Process
Limitations
Risks and Other Limitations of Genetic Testing
Medical Institutions to Reap the Benefit of Genetic Testing
Pharmacogenetics/Pharmacogenomics
Review of Select Genetic Tests
Cystic Fibrosis
Breast and Ovarian Cancer (BRCA)
Alzheimer's disease
Colorectal Cancer
Haemochromatosis (HH)
Cowden Syndrome
Huntington's disease (HD)
Costs of Select Tests

Table 24. Costs of Select Genetic Tests

Genetic Testing Techniques
Signal Amplification Technologies
PCR – New Developments
Quantitative Real-Time PCR for Molecular Diagnostics
Signal Detection and Quantification
Quantitative Real-Time RT-PCR Analysis
Applications of Quantitative Real-Time PCR Analysis
Viral Detection and Viral-Load Monitoring
Sensitive Detection of Infectious Disease Agents
Predisposition Testing
Non-PCR Methods
Other Signal Amplification Technologies
DNA Probe Based Products
Direct Detection of Specific Nucleic Acid Sequences
Nucleic Acid Amplification and Detection
DNA Sequencing and Gene Detection
Arrays of Immobilized Probes (DNA Chips) in Gene Detection
RNA Diagnostics

6. PRODUCT LAUNCHES/INNOVATIONS

PerkinElmer Launches Genetic Screening Processor Instruments in China
Mayo Clinic Launches Eight NGS Panels for Cardiac Disorders
Sequenom Laboratories and Recombine Launch HerediT UNIVERSAL Test
Multipicom NV Launches ADH MASTR v2 assay

23ANDME LAUNCHES DRUG DEVELOPMENT UNIT

Quest Diagnostics Launches Neurome Exome Sequencing Service
Roche Launches cobas 6800/8800 Systems
Agena Biosciences Launches MassARRAY 24-Well System
FDA Grants Marketing Approval to 23andMe’s DTC Bloom Syndrome Carrier Genetic Test
Transgenomic to Launch ICE COLD-PCR Technology
Rosetta Launches Sequencing-based Oncology Tests by Admera Health
MedGenome Labs Launches Panorama Prenatal Test
Ambry Genetics Launches CVD Genetic Testing Panels
Exceltox Launches Pharmacogenomic Testing
PerkinElmer Launches SCID Screening Test in North America
Quest Diagnostics Introduces BRCAvantage Plus
Genetic Technologies Launches BREVAGenplus Test
Sophia Genetics Receives CE-IVD Certification for Genetic Testing
Response Genetics Launches Immuno- Oncology Assay
DeNA Life Science Launches Mycode Genetic Testing Service
Pathway Genomics Launches BRCATrue Test
Courtagen Launches Genetic Sequencing Tests for Neurodevelopmental Disorders
Myriad Genetics Launches EndoPredict Breast Cancer Test
Assurex Health Expands GeneSight Pharmacogenomic Testing Platform
Illumina to Launch VeriSeq Embryo Screening Tool
GENEWIZ Launches PGxOne Pharmacogenomic Test
Ambry Genetics Launches ExomeNext and ExomeNext-Rapid Genetic Tests
Pathway Genomics Launches Genetic Test to Detect Risk of Colorectal Cancer
Mount Sinai Laboratory Develops Accurate Genetic Test for SMA
Sequenom Launches Non-Invasive Prenatal Test by Laboratoire Cerba
CSL Behring Launches Antitrypsin Deficiency Screening Test
Interleukin Genetics Launches PerioPredict
US Genomic Health Reports Positive Data from Oncotype DX Prostate Cancer Study
Assurex Health Launches GeneSight Test to Predict Folic Acid Conversion and Treat Depression
Verifi Prenatal Test Available Through California Prenatal Screening Program
Children’s Mercy Launches TaGSCAN Test
General Genetics and Estrogen Gene Test Launch EstroGene Test
Genetic Analysis Launches GA-map Test
Myriad Genetics Launches myRisk Hereditary Cancer Test
GeneDx Launches Genetic Tests for Cancer
ArcticDx Launches Vita Risk Pharmacogenetic Test for AMD Patients
Quest Diagnostics Launches CYP450 Biomarker- based Diagnostic Test
Blueprint Genetics Launches Gene Sequencing Tests
Bioiberica Farma Launches Genetic Test for Osteoarthritis
Illumina, The Wellcome Trust Centre and the Institute of Cancer Research Roll out Genetic Test
Aviir to Launch Genetic Testing for Inherited Cardiovascular Disease
Oxford University Hospitals Launches 46-gene Sequencing Test for Cancer

7. RECENT INDUSTRY ACTIVITY

ESPERITE Acquires InKaryo
Transgenomic Signs Agreement with Exiqon A/S
Quest Diagnostics and Myriad Genetics End BRCA Gene Patent Litigation
Roche to Acquire Majority Share of Foundation Medicine
Roche Acquires Ariosa Diagnostics
GSK Collaborates with GE on Oncology Genetic Testing
Cancer Genetics to Acquire Gentris Corporation
Natera Partners with Mount Sinai Genetic Testing Laboratory
Transgenomic to Sell SURVEYOR Nuclease Technology to Integrated DNA Technogies
Transgenomic Collaborates with Raptor Pharmaceuticals for Genetic Testing Services
AutoGenomic Signs Agreement with Genomas
Cancer Genetics Acquires BioServe Biotechnologies
PerkinElmer to Close Its Signature Genomics Testing Business
LifeLabs Medical Laboratory Services Buys out Centogene’s Canadian Business
CytoScan Dx Assay by Affymetrix Receives FDA Approval
NextGxDx Enters Agreement with PreventionGenetics
Neogen Acquires Scidera Genomics
Sequenom and CombiMatrix Enter Marketing Agreement for Chromosomal Microarray Analysis
Illumina Acquires Verinata Health

8. FOCUS ON SELECT GLOBAL PLAYERS

Abbott Laboratories (US)
Abbott Molecular, Inc. (US)
AutoGenomics, Inc. (US)
BioRad Laboratories (US)
ELITech Group S. P. A. (France)
PerkinElmer, Inc. (US)
Quest Diagnostics, Inc. (US)
Roche Diagnostics Corp. (Switzerland)
Roche Molecular Diagnostics, Inc. (US)
Thermo Fisher Scientific (US)
Transgenomic, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

Table 25. World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 26. World Historic Review for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 27. World 14-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
The US: Leading Market for Genetic Testing Globally
Demographic Changes Offer Growth Opportunities

Table 28. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Burgeoning Potential for Genetic Testing
Predictive Screening: Another Growth Area
An important Market for Personalized Medicine
Epidemic Proportion of Cancer in the US – Driver for Cancer Genetic Testing

Table 29. US Cancer Incidence by Gender (2014): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart)
Table 30. US Incidence of Common Cancers (2014): Number of New Cases Reported by Affected Site (includes corresponding Graph/Chart)

Newborn Testing Gains Ground
Success Stories
Favorable Reimbursement Policies
Favorable Insurance Coverage for Cystic Fibrosis Genetic Testing

Table 31. CF Carrier Screening: Percentage Breakdown of Population by Coverage Policy: 2012 (includes corresponding Graph/Chart)
Table 32. CF Diagnostic Testing: Percentage Breakdown of Population by Coverage Policy: 2012 (includes corresponding Graph/Chart)

Popularity of Screening and ACOG Guidelines Sink Invasive Prenatal Diagnosis Numbers

Table 33. US Annual Pregnancies by Age Group/Risk Profile: 2010 (includes corresponding Graph/Chart)

Tough Market Prospects for Sex Determination Tests
Sequenom Bets Big on MaterniT
IP Landscape of NIPD Tests
US Patents of cff DNA-based NIPD Tests
Direct-to-Consumer Testing - A Growing Market
DTC Genetic Tests Provide POCT for Patients in Hospice Care
Regulatory Environment
Genetic Information Nondiscrimination Act Boosts Genetic Testing
NIH Launches Public Database
Stricter Regulations for DTC Genetic Testing
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 34. The US Recent Past, Current & Future Analysis for Genetic Testing by Segment - Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 35. The US Historic Review for Genetic Testing by Segment - Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 36. The US 14-Year Perspective for Genetic Testing by Segment - Percentage Breakdown of Dollar Sales for Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Regulatory Scenario
Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand

Table 37. New Cancer Cases in Canada by Gender and Affected Site: 2012 (includes corresponding Graph/Chart)
Table 38. New Cancer Cases in Canada by Province: 2012 (includes corresponding Graph/Chart)
Table 39. New Cancer Cases in Canada by Age Group and Gender: 2012 (includes corresponding Graph/Chart)

Product Launch
Strategic Corporate Development
B. Market Analytics

Table 40. Canadian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 41. Canadian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Demographics Drive Market Growth

Table 42. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

DTC Genetic Testing Regulatory Scenario
Product Launch
B. Market Analytics

Table 43. Japanese Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 44. Japanese Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Debt Crisis in Europe Affects Healthcare Industry
European Healthcare System: In a State of Transition
An Insight into Molecular Diagnostics Markets in Europe
Cancer Trends

Table 45. Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Aging Population to Drive Demand for Genetic Testing

Table 46. Population Breakup by Age Group for Select European Countries: 2013 (as a Percentage of Total Population) (includes corresponding Graph/Chart)

European Personalized Medicine Market to Exhibit Robust Growth
Legislations/Regulatory Policies in Select European Countries
Legislations Governing Genetic Testing in Select European Countries
B. Market Analytics

Table 47. European Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48. European Historic Review for Genetic Testing by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49. European 14-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Regulatory Environment in France
Product Launch
Elitech Group S. P. A. - A Key Player
B. Market Analytics

Table 50. French Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 51. French Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Parliamentary Regulations
B. Market Analytics

Table 52. German Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 53. German Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4C. ITALY

Market Analysis

Table 54. Italian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 55. Italian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Increased Support for Personalized Medicine to Drive Genetic Testing
SMIP for Pharmacogenomic Testing
Increasing Need for Less Risky Prenatal Diagnostic Methods in the UK
Regulatory Scenario
Non-consensual Analysis of DNA Made Illegal
Principles for DTC Genetic Testing Laid out by HGC
Product Launches
B. Market Analytics

Table 56. The UK Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 57. The UK Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4E. REST OF EUROPE

A. Market Analysis
Product Launches
Strategic Corporate Developments
Roche Diagnostics Corp. – A Key Player (Switzerland)
B. Market Analytics

Table 58. Rest of European Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 59. Rest of European Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Healthcare Spending in Asia-Pacific: On the Rise
Select Regional Markets
China
China’s FDA Curbs Prenatal Testing

Table 60. China - The Most Populous Country Worldwide (July 2013): Total Population (in Millions) by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)
Table 61. China - The Most Populous Country Worldwide (July 2013): Percentage Population by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)

Diagnostics Market in India
Australia and New Zealand
Approval of Experiments on Human Embryos in New Zealand
Singapore Sets Guidelines for Genetic Research and Testing
Product Launches
Strategic Corporate Development
B. Market Analytics

Table 62. Asia-Pacific Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 63. Asia-Pacific Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

Market Analysis

Table 64. Rest of World Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 65. Rest of World Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 86 (including Divisions/Subsidiaries - 90)
The United States (58)
Canada (4)
Japan (1)
Europe (21)
  France (2)
  Germany (3)
  The United Kingdom (3)
  Spain (1)
  Rest of Europe (12)
Asia-Pacific (Excluding Japan) (6)
Skip to top


Global Genetic Testing Market Analysis US$ 1,200.00 Jan, 2012 · 65 pages

Ask Your Question

Genetic Testing: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: